Search hospitals > Nevada > Las Vegas

Comprehensive Cancer Centers of Nevada

Claim this profile
Las Vegas, Nevada 89148
Global Leader in Skin Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Prostate Cancer
Conducts research for Uterine Tumors
464 reported clinical trials
16 medical researchers
Photo of Comprehensive Cancer Centers of Nevada in Las VegasPhoto of Comprehensive Cancer Centers of Nevada in Las VegasPhoto of Comprehensive Cancer Centers of Nevada in Las Vegas

Summary

Comprehensive Cancer Centers of Nevada is a medical facility located in Las Vegas, Nevada. This center is recognized for care of Skin Cancer, Breast Cancer, Lung Cancer, Prostate Cancer, Uterine Tumors and other specialties. Comprehensive Cancer Centers of Nevada is involved with conducting 464 clinical trials across 461 conditions. There are 16 research doctors associated with this hospital, such as John A. Ellerton, Alan K. Ikeda, Fadi Braiteh, MD, and Nicholas Vogelzang, MD.

Area of expertise

1Skin Cancer
Global Leader
Comprehensive Cancer Centers of Nevada has run 133 trials for Skin Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage I
2Breast Cancer
Global Leader
Comprehensive Cancer Centers of Nevada has run 80 trials for Breast Cancer. Some of their research focus areas include:
Stage IV
HER2 negative
ER positive

Top PIs

Clinical Trials running at Comprehensive Cancer Centers of Nevada

Breast Cancer
Lung Cancer
Prostate Cancer
Bladder Cancer
Uterine Tumors
Cancer
Non-Small Cell Lung Cancer
Skin Cancer
Breast cancer
Bladder Carcinoma
Image of trial facility.

Sacituzumab Govitecan + Pembrolizumab

for Triple Negative Breast Cancer

The goal of this study is to find out if the experimental product, sacituzumab govitecan-hziy (SG) in combination with pembrolizumab given after surgery, is effective and safe compared to the treatment of physician's choice (TPC) which includes either pembrolizumab or pembrolizumab plus capecitabine in participants with triple negative breast cancer that still remains after surgery and pre-surgical treatment.
Recruiting2 awards Phase 36 criteria
Image of trial facility.

Giredestrant + Hormone Therapy

for Early-Stage Breast Cancer

This trial is testing giredestrant, a medication given after initial treatment to prevent breast cancer from returning. It focuses on patients with a specific type of early-stage breast cancer that is hormone-driven and at higher risk of recurrence. Giredestrant works by blocking the hormone estrogen from helping cancer cells grow. Giredestrant has shown promise in previous studies.
Recruiting2 awards Phase 311 criteria
Image of trial facility.

Sacituzumab Tirumotecan + Pembrolizumab

for Breast Cancer

Researchers want to know if sacituzumab tirumotecan given alone or with pembrolizumab can treat triple negative breast cancer (TNBC). The main goal of this study is to learn if people treated with sacituzumab tirumotecan alone or with pembrolizumab live longer overall or without the cancer growing or spreading compared to people treated with chemotherapy.
Recruiting2 awards Phase 33 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Comprehensive Cancer Centers of Nevada?
Comprehensive Cancer Centers of Nevada is a medical facility located in Las Vegas, Nevada. This center is recognized for care of Skin Cancer, Breast Cancer, Lung Cancer, Prostate Cancer, Uterine Tumors and other specialties. Comprehensive Cancer Centers of Nevada is involved with conducting 464 clinical trials across 461 conditions. There are 16 research doctors associated with this hospital, such as John A. Ellerton, Alan K. Ikeda, Fadi Braiteh, MD, and Nicholas Vogelzang, MD.
Where is Comprehensive Cancer Centers of Nevada located?
The Comprehensive Cancer Centers of Nevada is located at 7445 Peak Dr., Las Vegas, NV 89128. For directions, from downtown Las Vegas, take I-15 N to US-95 N towards Henderson, exit 81A for Summerlin Pkwy W, continue on Lake Mead Blvd, then turn right onto Peak Dr. The hospital will be on your left.
Who should I call to ask about financial aid or insurance network?
For general health insurance inquiries in Nevada, contact the Office of the Consumer Health Advocate at 1-888-333-1597. For employer-provided insurance questions, reach out to the Nevada Division of Insurance at (888) 872-3234. Comprehensive Cancer Centers of Nevada offers financial counseling to assist with treatment costs and insurance matters; visit their Contact Us page for more information.
What insurance does Comprehensive Cancer Centers of Nevada accept?
The Comprehensive Cancer Centers of Nevada accept a wide range of insurance plans, including commercial insurance, Medicare, Medicare Part C, Medicaid in some cases, and certain U.S. Department of Veterans Affairs and TRICARE plans. For detailed information on coverage, it is recommended to contact an Oncology Information Specialist at the center.
What awards or recognition has Comprehensive Cancer Centers of Nevada received?
Comprehensive Cancer Centers of Nevada (CCCN) is recognized for its excellence in clinical care and research, having been designated as a Comprehensive Cancer Center by the National Cancer Institute (NCI). Its physicians were named Best Doctors by Healthcare Quarterly and Desert Companion in 2021. CCCN actively participates in over 170 clinical trials annually, contributing to the development of more than 100 FDA-approved cancer therapies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security